Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
CureVac N.V. (NASDAQ:CVAC)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Sep 22|
|Day's Range||52.83 - 55.67|
|52 Week Range||43 - 151.8|
CureVac N.V. dividends
CureVac N.V. has a market cap or net worth of $10.34 billion. The enterprise value is $0.
CureVac N.V. has 186.91 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is 649.5757. CureVac N.V.'s PEG ratio is 0.0000.
Stock Price Statistics
The stock price has decreased by -0.3390%. The beta is 1.2516, so CureVac N.V.'s price volatility has been higher than the market average.
In the last 12 months, CureVac N.V. had revenue of $0 and earned $0 in profits. Earnings per share was $.
CureVac N.V. operates as a global clinical-stage biopharmaceutical company.
The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide..